BioNTech SE BNTX

$BNTX 100$ eod.

Eli Lilly pauses trial of its monoclonal antibody to treat coronavirus

https://www.msn.com/en-us/health/medical/eli-lilly-pauses-trial-of-its-monoclonal-antibody-to-treat-coronavirus/ar-BB19Zp0h

$BNTX coming soon to a hospital near you.

https://www.google.com/amp/s/www.businessinsider.com/pfizer-expands-coronavirus-vaccine-trial-to-include-teenagers-2020-10%3famp

https://www.google.com/amp/s/www.politico.com/amp/news/2020/10/09/coronavirus-vaccine-pfizer-election-day-428371

https://kfgo.com/2020/10/09/health-canada-to-start-real-time-review-of-pfizer-biontech-covid-19-vaccine/

Today will likely be last chance to get stock under $90.

It all depends on the reported efficacy.
My guesses:
90%: 400s
80%: 300s
75%: 200s

The higher the reported efficacy the smaller the competition.

Also keep in mind for each company that fails the more valuable this stock becomes.

If you don’t own this stock over the weekend you’re going to regret if any good news comes out over the weekend.

It’s my understanding that BNTX has already declined being bought out. Why would you sell your company off if your technology is the newest way to solve cancers and it was the first to solve Covid? If BNTX vaccine works then all of their drugs in their pipeline will benefit. The Covid problem is just easier to predict since several contracts have already been signed.